Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trial

References

• FabbriLMLuppiFBegheBRabeKFComplex chronic comorbidities of COPDEur Respir J200831120421218166598
   PubMed Web of Science ®Google Scholar
• SinDDWuLManSFThe relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literatureChest200512761952195915947307
   PubMed Web of Science ®Google Scholar
• McGarveyLPJohnMAndersonJAZvarichMWiseRAAscertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint CommitteeThorax200762541141517311843
   PubMed Web of Science ®Google Scholar
• ColhounHMBetteridgeDJDurringtonPNPrimary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trialLancet2004364943568569615325833
   PubMed Web of Science ®Google Scholar
• SoysethVBrekkePHSmithPOmlandTStatin use is associated with reduced mortality in COPDEur Respir J200729227928317050558
   PubMed Web of Science ®Google Scholar
• ManciniGBEtminanMZhangBReduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary diseaseJ Am Coll Cardiol200647122554256016781387
   PubMed Web of Science ®Google Scholar
• RidkerPMDanielsonEFonsecaFARosuvastatin to prevent vascular events in men and women with elevated C-reactive proteinN Engl J Med2008359212195220718997196
   PubMed Web of Science ®Google Scholar
• LaurentSBoutouyriePAsmarRAortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patientsHypertension20013751236124111358934
   PubMed Web of Science ®Google Scholar
• Ben-ShlomoYSpearsMBoustredCAortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjectsJ Am Coll Cardiol201463763664624239664
   PubMed Web of Science ®Google Scholar
• SabitRBoltonCEEdwardsPHArterial stiffness and osteoporosis in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2007175121259126517363772
   PubMed Web of Science ®Google Scholar
• MaclayJDMcAllisterDAMillsNLVascular dysfunction in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2009180651352019542477
   PubMed Web of Science ®Google Scholar
• FerrierKEMuhlmannMHBaguetJPIntensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertensionJ Am Coll Cardiol20023961020102511897445
   PubMed Web of Science ®Google Scholar
• MengXQieLWangYZhongMLiLAssessment of arterial stiffness affected by atorvastatin in coronary artery disease using pulse wave velocityClin Invest Med2009326E23820003828
   PubMed Web of Science ®Google Scholar
• Maki-PetajaKMBoothADHallFCEzetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritisJ Am Coll Cardiol200750985285817719471
   PubMed Web of Science ®Google Scholar
• SinDDLacyPYorkEManSFEffects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2004170776076515229100
   PubMed Web of Science ®Google Scholar
• MillerJEdwardsLDAgustíAComorbidity, systemic inflammation and outcomes in the ECLIPSE cohortRespir Med201310791376138423791463
   PubMed Web of Science ®Google Scholar
• WuYWKaoHLHuangCLThe effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkersEur J Nucl Med Mol Imaging201239339940722109668
   PubMed Web of Science ®Google Scholar
• CrinerGJConnettJEAaronSDSimvastatin for the prevention of exacerbations in moderate-to-severe COPDN Engl J Med2014370232201221024836125
   PubMed Web of Science ®Google Scholar
• ArmitageJBowmanLWallendszusKIntensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trialLancet201037697531658166921067805
   PubMed Web of Science ®Google Scholar
• LaurentSCockcroftJVan BortelLExpert consensus document on arterial stiffness: methodological issues and clinical applicationsEur Heart J200627212588260517000623
   PubMed Web of Science ®Google Scholar
• CrapoROCasaburiRCoatesALATS statement: guidelines for the six-minute walk testAm J Respir Crit Care Med2002166111111712091180
   PubMed Web of Science ®Google Scholar
• FriedewaldWTLevyRIFredricksonDSEstimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugeClin Chem19721864995024337382
   PubMed Web of Science ®Google Scholar
• VlachopoulosCAznaouridisKStefanadisCPrediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysisJ Am Coll Cardiol201055131318132720338492
   PubMed Web of Science ®Google Scholar
• Van BortelLMLaurentSBoutouyriePExpert consensus document on the measurement of aortic stiffness in daily practice using carotid- femoral pulse wave velocityJ Hypertens201230344544822278144
   PubMed Web of Science ®Google Scholar
• BoutouyriePHofmanAVerwoertGCDeterminants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’Eur Heart J201031192338235020530030
   PubMed Web of Science ®Google Scholar
• ManciaGFagardRNarkiewiczK2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)Eur Heart J201334282159221923771844
   PubMed Web of Science ®Google Scholar
• JohnMHussainSPrayleATarget renal damage: the microvascular associations of increased aortic stiffness in patients with COPDRespir Res2013143123497267
   PubMed Web of Science ®Google Scholar
• DransfieldMTCockcroftJRTownsendRREffect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPDRespir Med201110591322133021696934
   PubMed Web of Science ®Google Scholar
• SinDDManSFPWhy are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary diseaseCirculation2003107111514151912654609
   PubMed Web of Science ®Google Scholar
• RidkerPMRifaiNRoseLBuringJECookNRComparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular eventsN Engl J Med2002347201557156512432042
   PubMed Web of Science ®Google Scholar
• Pinto-PlataVMMullerovaHTosoJFC-reactive protein in patients with COPD, control smokers and non-smokersThorax2006611232816143583
   PubMed Web of Science ®Google Scholar
• LowreyGEHendersonNBlakeyJDCorneJMJohnsonSRMMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPDRespir Med2008102684585118328682
   PubMed Web of Science ®Google Scholar
• BastaGReceptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implicationsAtherosclerosis2008196192117826783
   PubMed Web of Science ®Google Scholar
• O’DriscollGGreenDTaylorRRSimvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 monthCirculation1997955112611319054840
   PubMed Web of Science ®Google Scholar
• MasonRPWalterMFJacobRFEffects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stressCirculation200410921 Suppl 1II34II4115173061
   PubMed Web of Science ®Google Scholar
• LeeTMLinMSChangNCUsefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatinAm J Cardiol2008101453053518312772
   PubMed Web of Science ®Google Scholar
• YasminMcEnieryCMWallaceSMatrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffnessArterioscler Thromb Vasc Biol200525237215556929
   PubMed Web of Science ®Google Scholar
• CoulsonJMRuddJHFDuckersJMExcessive aortic inflammation in chronic obstructive pulmonary disease: an 18F-FDG PET pilot studyJ Nucl Med20105191357136020720052
   PubMedGoogle Scholar
• AlexeeffSELitonjuaAASparrowDVokonasPSSchwartzJStatin use reduces decline in lung function: VA Normative Aging StudyAm J Respir Crit Care Med2007176874274717673694
   PubMed Web of Science ®Google Scholar